An Open Label Study of the Long-term Safety of Dapoxetine HCl in the Treatment of Rapid Ejaculation.

Trial Profile

An Open Label Study of the Long-term Safety of Dapoxetine HCl in the Treatment of Rapid Ejaculation.

Completed
Phase of Trial: Phase III

Latest Information Update: 08 Jul 2017

At a glance

  • Drugs Dapoxetine (Primary)
  • Indications Premature ejaculation
  • Focus Adverse reactions
  • Sponsors ALZA Corporation
  • Most Recent Events

    • 10 Nov 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top